Mar-27-24 10:23AM
|
|
Mar-12-24 07:30AM
|
|
Mar-07-24 10:00AM
|
|
Feb-27-24 04:03PM
|
|
Feb-26-24 08:00AM
|
|
08:00AM |
Loading… |
Feb-07-24 08:00AM
|
|
Feb-04-24 03:29PM
|
|
Jan-19-24 08:28PM
|
|
Jan-03-24 08:00AM
|
|
Nov-13-23 04:30PM
|
|
Nov-09-23 04:05PM
|
|
08:44AM
|
|
Nov-08-23 08:00AM
|
|
Nov-07-23 10:00AM
|
|
Nov-06-23 08:00AM
|
|
04:03PM |
Loading… |
Oct-31-23 04:03PM
|
|
Oct-19-23 08:00AM
|
|
Oct-16-23 04:05PM
|
|
Sep-28-23 09:58AM
|
|
Sep-27-23 10:52AM
|
|
09:01AM
|
|
Sep-26-23 02:26PM
|
|
12:10PM
|
|
07:30AM
|
|
Sep-25-23 04:05PM
|
|
Sep-15-23 08:00AM
|
|
Sep-11-23 08:00AM
|
|
Aug-30-23 08:00AM
|
|
Aug-28-23 04:05PM
|
|
10:22AM
|
|
05:15PM |
Loading… |
Aug-09-23 05:15PM
|
|
04:03PM
|
|
08:00AM
|
|
Jul-28-23 03:57PM
|
|
Jul-25-23 08:00AM
|
|
Jun-23-23 07:30AM
|
|
Jun-05-23 08:02PM
|
|
06:19AM
|
|
May-24-23 08:00AM
|
|
May-18-23 01:50PM
|
|
May-10-23 08:05AM
|
|
May-09-23 05:45PM
|
|
04:02PM
|
|
May-04-23 06:25PM
|
|
Apr-30-23 02:10PM
|
|
Apr-12-23 08:01AM
|
|
Apr-09-23 01:19PM
|
|
Mar-27-23 08:01AM
|
|
Mar-13-23 08:01AM
|
|
Mar-11-23 07:29AM
|
|
Mar-09-23 06:15PM
|
|
04:05PM
|
|
Mar-08-23 04:01PM
|
|
Mar-05-23 07:55AM
|
|
Mar-01-23 08:01AM
|
|
Feb-24-23 01:03PM
|
|
Feb-07-23 08:01AM
|
|
Feb-02-23 08:02AM
|
|
07:45AM
|
|
Jan-27-23 04:03PM
|
|
Jan-26-23 04:16PM
|
|
Jan-25-23 10:21AM
|
|
08:01AM
|
|
Jan-24-23 09:19PM
|
|
Jan-23-23 04:11PM
|
(Investor's Business Daily) +34.52% |
04:01PM
|
|
08:59AM
|
|
07:49AM
|
|
06:16AM
|
|
Jan-22-23 02:00PM
|
|
Jan-12-23 04:55AM
|
|
Jan-03-23 08:00AM
|
|
Dec-25-22 07:39AM
|
|
Dec-15-22 08:00AM
|
|
Dec-08-22 09:38AM
|
|
Nov-15-22 08:00AM
|
|
Nov-08-22 05:15PM
|
|
04:02PM
|
|
Oct-25-22 09:40AM
|
|
Oct-19-22 12:02PM
|
|
Oct-05-22 08:00AM
|
|
Sep-26-22 07:01AM
|
|
Sep-15-22 09:39AM
|
|
08:00AM
|
|
Sep-09-22 01:42PM
|
(Investor's Business Daily) +9.13% |
Sep-07-22 10:12AM
|
|
Sep-06-22 09:40AM
|
|
Sep-05-22 12:00PM
|
|
Sep-02-22 12:29PM
|
|
Sep-01-22 09:55AM
|
|
08:00AM
|
|
Aug-30-22 08:00AM
|
|
Aug-16-22 08:26AM
|
|
Aug-15-22 09:55AM
|
|
Aug-10-22 08:19AM
|
|
Aug-09-22 07:40AM
|
|
Aug-08-22 05:25PM
|
|
04:05PM
|
|
Aug-05-22 11:55AM
|
|
Aug-04-22 01:43PM
|
|
|
|
|
Pliant Therapeutics, Inc. engages in the discovery and development of therapies for fibrotic diseases. It offers product discovery engine. The company is pursuing drug development programs for a range of fibrotic diseases, focusing on tissue-specific integrin modulation and TGF-ß1 signaling inhibition. The company was founded by Bradley Backes, Bill De Grado, Hal Chapman, and Dean Sheppard in June 2015 and is headquartered in South San Francisco, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Coulie Bernard | President and CEO | Jan 17 '24 | Sale | 17.23 | 25,721 | 443,173 | 316,382 | Jan 19 05:19 PM | Lefebvre Eric | Chief Medical Officer | Jan 17 '24 | Sale | 17.23 | 10,295 | 177,383 | 156,920 | Jan 19 05:18 PM | Hull Hans | Chief Business Officer | Jan 17 '24 | Sale | 17.23 | 9,786 | 168,613 | 185,069 | Jan 19 05:19 PM | Cummings Keith Lamont | Chief Financial Officer | Jan 17 '24 | Sale | 17.23 | 9,781 | 168,527 | 194,605 | Jan 19 05:19 PM | Ouimette Mike | General Counsel & Corp. Sec'y | Jan 17 '24 | Sale | 17.23 | 5,197 | 89,544 | 55,246 | Jan 19 05:11 PM | Hull Hans | Chief Business Officer | Aug 04 '23 | Option Exercise | 2.08 | 8,791 | 18,285 | 214,905 | Aug 07 08:50 PM | Hull Hans | Chief Business Officer | Aug 04 '23 | Sale | 20.01 | 20,050 | 401,201 | 194,855 | Aug 07 08:50 PM | Hull Hans | Chief Business Officer | Aug 03 '23 | Option Exercise | 2.08 | 1,800 | 3,744 | 207,914 | Aug 07 08:50 PM | Hull Hans | Chief Business Officer | Aug 03 '23 | Sale | 20.00 | 13,069 | 261,380 | 206,114 | Aug 07 08:50 PM | Ouimette Mike | General Counsel & Corp. Sec'y | Jul 20 '23 | Sale | 17.55 | 4,755 | 83,450 | 60,443 | Jul 21 04:40 PM | Coulie Bernard | President and CEO | Jul 17 '23 | Sale | 18.01 | 70,150 | 1,263,338 | 342,103 | Jul 19 08:20 PM | Lefebvre Eric | Chief Medical Officer | Jul 17 '23 | Sale | 18.01 | 22,321 | 401,981 | 167,215 | Jul 19 08:29 PM | Cummings Keith Lamont | Chief Financial Officer | Jul 17 '23 | Sale | 18.01 | 19,771 | 356,058 | 203,999 | Jul 19 08:23 PM | Hull Hans | Chief Business Officer | Jul 17 '23 | Sale | 18.01 | 17,937 | 323,029 | 219,183 | Jul 19 08:26 PM | Ouimette Mike | General Counsel & Corp. Sec'y | Jul 17 '23 | Sale | 18.01 | 12,778 | 230,120 | 65,198 | Jul 19 08:31 PM | Cummings Keith Lamont | Chief Financial Officer | Jun 13 '23 | Option Exercise | 2.08 | 30,750 | 63,960 | 185,020 | Jun 14 06:14 PM | Cummings Keith Lamont | Chief Financial Officer | Jun 09 '23 | Option Exercise | 2.08 | 5,800 | 12,064 | 154,270 | Jun 12 06:19 PM | Ouimette Mike | General Counsel & Corp. Sec'y | Apr 03 '23 | Sale | 26.79 | 2,877 | 77,066 | 50,789 | Apr 03 07:07 PM | Coulie Bernard | President and CEO | Mar 30 '23 | Sale | 26.52 | 35,339 | 937,222 | 274,753 | Apr 03 06:46 PM | Lefebvre Eric | Chief Medical Officer | Mar 30 '23 | Sale | 26.52 | 11,245 | 298,228 | 145,786 | Apr 03 07:01 PM | Cummings Keith Lamont | Chief Financial Officer | Mar 30 '23 | Sale | 26.52 | 9,960 | 264,148 | 148,470 | Apr 03 06:48 PM | Hull Hans | Chief Business Officer | Mar 30 '23 | Sale | 26.52 | 9,036 | 239,643 | 201,964 | Apr 03 06:51 PM | Ouimette Mike | General Counsel & Corp. Sec'y | Mar 30 '23 | Sale | 26.52 | 4,874 | 129,263 | 53,666 | Apr 03 07:07 PM |
|